pt141 Bremelanotide (PT-141) Nasal Spray PT-141-Nasal Spray - Shell Medical
Description
A phase I/II study of live biotherapeutic MRx0518 in combination with pembrolizumab in patients refractory to immune checkpoint inhibitors
January 12, 1988
K., Perugu, S
Although it remains to be tested in clinical trials, the use of meldonium in preoperative management of patients subjected to surgical resection or liver transplantation represents an entirely new therapeutic approach in this field
Judith M
